SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Tejnaksh Healthcare’s research lab gets renewal of DSIR approval

05 Apr 2025 Evaluate

Tejnaksh Healthcare’s research lab has been granted renewed approval by the Department of Scientific and Industrial Research (DSIR) for the next two years. This approval not only reinforces its position as a leader in the healthcare and research domain but also enhances the credibility of the work the company do in partnership with its collaborators and research teams.

The DSIR’s recognition underscores the importance of translational research and its application in improving healthcare practices on a global scale. 

Tejnaksh Healthcare owns and operates a hospital under the brand name of the Institute of Urology.

Tejnaksh Healthcare Share Price

15.40 0.34 (2.26%)
20-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×